AIP completes acquisition of Avanos for $1.272B; stockholders receive $25.00/share cash

AVANOS MEDICAL, INC.

Deal valued at ~$1.272B; Avanos stockholders get $25.00 per share in cash.
Avanos common stock delisted from NYSE; company becomes private.
New board: David Pacitti CEO, Scott Galovan CFO, John Fischer General Counsel.
Credit agreement: $675M term loan, $100M DDTL, $100M revolver, matures 2033.
Prior directors resigned; Joel Rotroff (AIP) initially appointed then replaced.

item 1.01 item 1.02 item 2.01 item 2.03 item 3.01 item 3.03 item 5.01 item 5.02 item 5.03 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.